Trio ExomeXtra®

The most effective genetic test for patients with complex, heterogeneous, and unspecific symptoms

Trio ExomeXtra® is used to diagnose an affected patient with unaffected parents. Including both unaffected parents in the analysis significantly increases the chances of a successful diagnosis. For Trio ExomeXtra®, the exomes of the parents and the index patient are sequenced. This allows an exome-wide segregation analysis and, thus the highest solution rates. Comparative exome diagnostics is particularly effective because the number of variants to be evaluated is minimized, and single variants’ numerous and cost-intensive segregation analyses are avoided.

In addition to SNVs and CNVs, we also check for uniparental disomies (UPD), covering both isodisomies as well as heterodisomies affecting whole or partial chromosomes.

Are you insured in Germany? Our colleagues at the Zentrum für Humangenetik Tübingen will gladly support you!

What We Offer with This Service

Clinical Design

All known disease-causing regions throughout the genome are covered


Including variants in genes with reduced penetrance, variable expressivity and imprinting effects


Average diagnostic coverage of > 100x

Comprehensive Medical Report

Created by our interdisciplinary team of experts

Our Promise to You

Fast Turnaround Time

4 – 6 weeks* after sample receipt


Highest confidentiality and quality standards


Reliable support throughout all steps


Clearly prepared medical report

* Due to high demand and a large number of urgent and prenatal cases, our turnaround time is currently slightly increased. For urgent samples, our processing time will of course remain 2-3 weeks.

Service Details

Medical Report with:

  • Variants with clinical relevance (ACMG class 3, 4, 5) – more information
  • Interpretation & discussion of these variants and the affected genes
  • Interpretation of genetic relevance for family planning
  • Recommendations for clinical disease management & further tests
  • Detection of copy number variants (CNV) – more information

Additional Services:

Sample Report

Our Standard Sample Requirements

  • 1-2 ml EDTA blood (recommended sample type)
  • Genomic DNA (1-2 µg)
  • DBS cards, buccal swabs, or saliva are also possible

Here you can find more information on how to ship your sample safely.

Other sample material sources are possible on request. Please note: In case of insufficient sample quality, the analysis might fail. If you have more than one option of samples, please contact us ( and we will assist you in choosing the optimal sample for your patient.

Diagnostic Process

Icon process flow

Counseling & Test Selection

Icon process flow
Icon process flow

Sampling & Shipment

Icon process flow
Icon process flow

Sample Analysis

Icon process flow
Icon process flow

Medical Report & Counseling

Benefit From Our Comparative ExomeXtra®

In the evaluation process, our experienced team investigates all variants according to the latest scientific knowledge. For variants in genes that are not clearly associated, with the patient’s suspected phenotype, we predict the possible contribution through extensive additional literature research. If we find evidence that a variant not yet described contributes to the patient’s phenotype, this variant is described in our medical report.

Comparison of the affected patient’s data with those of the unaffected parents allows us to identify the following SNV/CNV combinations:

  • De novo – new in the index, not present in parents
  • Homozygous – homozygous in the index, heterozygous in both parents
  • Compound heterozygous – two or more variants in the same gene in the index on different alleles; each parent is a heterozygous carrier of one variant
  • X-linked – male patient is hemizygous, the mother is heterozygous
  • Loss of heterozygosity – index is homozygous, one parent heterozygous, other parent wildtype
  • Parental mosaicism – index is heterozygous, one parent has a genetic mosaicism


Image of filter for Trio ExomeExtra®

Extra Insightful Results

Our Unique Analysis Strategy Considers Often Overlooked Issues, Such as Mildly Affected Parents

Standard trio exome diagnostics rely on the assumption that both parents are not affected. This filtering ignores that some parents are only mildly affected, for example, which would result in negative findings. We compensate for these situations with a unique analysis strategy that allows us to solve cases where the phenotype is caused by variants with

  • reduced penetrance
  • variable expressivity
  • imprinting effects

In addition, variants in the mitochondrial genome are evaluated when the phenotype indicates the possibility of a mitochondrial disease. In the case of prenatal diagnostics, the analysis of mtDNA is always included.

We also detect and report uniparental disomies (UPD). UPDs can cause diseases due to imprinting effects, underlying homozygous pathogenic variants, or low-level mosaic aneuploidies. We are able to report on all four possible UPD constellations: maternal heterodisomies maternal isodisomies, paternal heterodisomies, and paternal isodisomies.

Figure to explain uniparental disomies (UPD).

Figure 2: A) normally, one copy of each chromosome is inherited from each parent. B) uniparental disomy (UPD) is the case where both pairs of chromosomes are inherited from only one parent, which means the other parent’s chromosome for that pair is missing. The figure shows the possible types of UPDs that can occur, which may be inherited maternally (both red) or paternally (both blue). UPDs are also further sub-categorized depending on the constellation; if one chromosome is inherited in a duplicated fashion (isodisomy) or if each chromosomes in the pair is inherited (heterodisomy).

Extra Thorough Analysis

In comparative family exome diagnostics, not only the affected patient but also other relatives are sequenced. The most commonly performed analysis is the trio exome: The inclusion of both unaffected parents of the index patient highly increases the chances of diagnostic success to be approximately twice as high compared to single exome diagnostics1.

In family constellations where it is not possible to obtain a sample from both genetic parents, or one parent might be affected as well, the adaptive ExomeXtra® bioinformatic pipeline allows us to analyze all kinds of family combinations, like duos.

This goes beyond commonly performed analyses of private and shared variants between two persons. Our additional analyses are the best approach for solving cases with only one parent (affected or unaffected) or any other indexrelative constellations. A detailed phenotypic description of all affected individuals is the basis for a precise and successful data interpretation.


1 Farwell, K. D. et al. Enhanced utility of family-centered diagnostic exome sequencing with inheritance model-based analysis: results from 500 unselected families with undiagnosed genetic conditions. Genetics in medicine : official journal of the American College of Medical Genetics 17, 578–586; 10.1038/gim.2014.154 (2015).

Further Information

Webinar: Better than exome, smarter than genome

Dr. Dr. Saskia Biskup about ExomeXtra®

Trio exome diagnostics: One of the most powerful tools in genetic diagnostics

Designing the best possible exome

Identifiy the disease-causing alteration in a fetus

Exome diagnostics saved a little girl’s life

Case report: Saving a little girl‘s life.


Order Form ExomeXtra®
Sample Report Trio ExomeXtra®
Exome Diagnostics Brochure
Exome Diagnostics Flyer (EN)
Revolution in Exome Diagnostics

Contact Us

Do you have a question, or are you interested in our service?

Diagnostic Support

We will assist you in selecting the diagnostic strategy – for each patient.

Diagnostic support team of CeGaT